In this chapter, we provide an overview of how (Quantitative) Structure Activity Relationships, (Q)SARs, are validated and applied for regulatory purposes. We outline how chemical categories are derived to facilitate endpoint specific readacross using tools such as the OECD QSAR Toolbox and discuss some of the current difficulties in addressing the residual uncertainties of read-across. Finally we put forward a perspective of how non-testing approaches may evolve in light of the advances in new and emerging technologies and how these fit within the Adverse Outcome Pathway (AOP) framework.
CITATION STYLE
Patlewicz, G., Worth, A. P., & Ball, N. (2016). Validation of computational methods. In Advances in Experimental Medicine and Biology (Vol. 856, pp. 165–187). Springer New York LLC. https://doi.org/10.1007/978-3-319-33826-2_6
Mendeley helps you to discover research relevant for your work.